This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Redona Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sven Weiler: Innovator in Cancer Treatment
Introduction
Sven Weiler is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Sven Weiler holds a patent for "Benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives for the treatment of cancer." This invention provides compounds of formula (IA) and compounds of formula (IB), along with pharmaceutically acceptable salts. The compounds are designed to treat neoplastic diseases, particularly cancer, by utilizing specific chemical structures and methods of application.
Career Highlights
Weiler is currently associated with Redona Therapeutics, Inc., where he continues to advance his research in oncology. His work focuses on developing effective treatments that can significantly impact patient outcomes in cancer therapy.
Collaborations
Sven collaborates with talented professionals in his field, including Bérangère Gaucher and Florian Richalet. These partnerships enhance the innovative potential of his research and contribute to the advancement of cancer treatment solutions.
Conclusion
Sven Weiler's contributions to cancer treatment through his patented inventions and collaborative efforts highlight his commitment to improving healthcare outcomes. His work exemplifies the importance of innovation in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile